Bristol-Myers Squibb Co (XSWX:BMY) Interest Expense : CHF-1,157 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Bristol-Myers Squibb Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bristol-Myers Squibb Co's interest expense for the three months ended in Mar. 2024 was CHF -378 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was CHF-1,157 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bristol-Myers Squibb Co's Operating Income for the three months ended in Mar. 2024 was CHF 1,345 Mil. Bristol-Myers Squibb Co's Interest Expense for the three months ended in Mar. 2024 was CHF -378 Mil. Bristol-Myers Squibb Co's Interest Coverage for the quarter that ended in Mar. 2024 was 3.56. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bristol-Myers Squibb Co Interest Expense Historical Data

The historical data trend for Bristol-Myers Squibb Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Interest Expense Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-644.59

-1,261.53

-1,228.61

-1,147.73

-1,008.36

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-266.54	-253.91	-251.89	-273.28	-377.66

Bristol-Myers Squibb Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-1,157 Mil.

Bristol-Myers Squibb Co (XSWX:BMY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bristol-Myers Squibb Co's Interest Expense for the three months ended in Mar. 2024 was CHF-378 Mil. Its Operating Income for the three months ended in Mar. 2024 was CHF1,345 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was CHF45,363 Mil.

Bristol-Myers Squibb Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	1345.34	/	-377.655
	=	3.56

The higher the ratio, the stronger the company's financial strength is.

Bristol-Myers Squibb Co (XSWX:BMY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (XSWX:BMY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.